Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-03

Clinical Trial Update: Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating integration of HPV vaccination and HPV-based cervical screening into ARV clinics (H2VICTORY).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: International Agency for Research on Cancer | Conditions: HPV Infection | Phase 3 | Status: NOT_YET_RECRUITING